Brain Computer Interface Control of Functional Electrical Stimulation for a Hand Therapy in Tetraplegic Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Spinal Cord Injury
- Sponsor
- NHS Greater Glasgow and Clyde
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Muscle strength as measured by the Oxford manual test
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study will assess whether functional recovery of the hand muscles in patients with spinal cord injury is enhanced when electrical stimulation of the muscles is delivered actively by means of using the electroencephalography wave patterns arising from the patient imagining moving their hand to operate the stimulator. A control group will obtain the electrical stimulation treatment passively by a therapist operating the machine.
Detailed Description
Injuries of the higher levels of the spinal cord, called tetraplegia, result in a complete or partial paralysis of both legs and arms, making the person dependent on their caregivers for elementary activities of daily living (ADL) such as drinking and feeding. About 60% of tetraplegics have an incomplete injury and can partially recover their movement and sensation. The success of a recovery greatly depends on the therapy within the first year after the injury. Functional electrical stimulation (FES) is a relatively novel therapy of the hand. In FES therapy electrodes are attached on the surface the patients's forearms and electrical current is delivered through them. A disadvantage of the current FES therapy is that a therapist has to switch the stimulator on and off because patients cannot use either of their hands. In our previous pilot study performed on two acute tetraplegic patients we tested feasibility of using brain-computer interface (BCI) to control FES on patient's will. BCI is based on recording the patient's brain activity. BCI can detect the patient's intention to move the hand even if they are not able to physically move it. Using BCI, patients control the FES by thinking to move their hand. A BCI-FES therapy will provide a simultaneous training of neural pathways from the brain to the hand muscle (motor imagination/attempt) and from the muscle to the brain (electrical stimulation of muscles). This form of therapy could promote faster and more complete recovery In this controlled study we aim to provide a BCI-FES therapy to both chronic and subacute tetraplegic patients over a period of 20 sessions and to access the functional and neurological outcome of the therapy. Five chronic patients (more than a year after the injury) will participate in a cross-over study as we do not expect that they will recover spontaneously without BCI-FES. Subacute patients will be receiving both a conventional therapy and BCI-FES so recovery can be caused by either of these two therapies. Therefore it is necessary to have a treatment and a control group. Each group will have 10 patients, age and injury matched. Both groups will receive the same amount of electrical stimulation but only the treatment group will voluntarily control the electrical stimulator using BCI. A control group will receive passive electrical stimulation of the same hand muscles but without using BCI.
Investigators
Eligibility Criteria
Inclusion Criteria
- •incomplete (ASIA B, C) tetraplegia with injury at level C4-C8
- •aged between 18 and 70 years old
- •a candidate suitable for the conventional therapy
Exclusion Criteria
- •Patients must not have presence of any neurological problem that might distort recording standard brain signal during motor imagination (example: brain damage, epilepsy, Parkinson disease and multiple sclerosis)
- •Patients must not have cognitive impairments (hearing, vision and general inability to understand instructions)
- •Patients must not suffer from recurring pressure sore which prevent patient from sitting for at least an hour
- •Patients must not suffer from excessive spasm that would increase with electrical stimulation.
Outcomes
Primary Outcomes
Muscle strength as measured by the Oxford manual test
Time Frame: Between initial and final assessment after up to 8 weeks of treatment
Secondary Outcomes
- Difference in Somatosensory evoked potential between the treatment and control group(Between initial and final assessment after up to 8 weeks of treatment)
- Difference in EEG between the treatment and the control group(Between initial and final assessment after up to 8 weeks of treatment)
- Difference in somatosensory evoked potential before and after a treatment session(Between initial and final assessment after up to 8 weeks of treatment)
- Range of movement of wrists and fingers(Between initial and final assessment after up to 8 weeks of treatment)
- Changes in patients EEG before and after each treatment session(between beginning and end of each one hour treatment session)
- Patient's experience of using BCI-FES(Between initial and final assessment after up to 8 weeks of treatment)
- Quadriplegia index of function(Between initial and final assessment after up to 8 weeks of treatment)